...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Journal of pharmacy technology: jPT : official publication of the Association of Pharmacy Technicians >Hepatitis C Virus Screening: A Review of the OraQuick Hepatitis C Virus Rapid Antibody Test
【24h】

Hepatitis C Virus Screening: A Review of the OraQuick Hepatitis C Virus Rapid Antibody Test

机译：丙型肝炎病毒筛查：OraQuick丙型肝炎病毒快速抗体检测的综述

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: To provide a review on the use, percent positive agreement (PPA), percent negative agreement (PNA), and implementation of using the OraQuick HCV Rapid Antibody Test for hepatitis C virus (HCV) screening in community pharmacies in an effort to increase overall HCV screening in target populations. Data Sources: PubMed and Sagepub were searched for the following : hepatitis C virus, rapid diagnostic tests, rapid assay, and rapid HCV assay. Dates searched were from January 2000 to October 2013. Study Selection: All studies including the use of the OraQuick HCV Rapid Antibody Test were included. Data Synthesis: Sensitivity and specificity of this device are compared with several standard laboratory tests for detecting HCV antibodies. In comparing these values with the clinical "standards," PPA and PNA are more applicable terms to describe whether the OraQuick device is an effective tool for initial screening by pharmacists. The OraQuick HCV Rapid Antibody Test demonstrates high accuracy in providing accurate HCV infection status. Conclusion: The OraQuick HCV Rapid Antibody Test is a unique tool pharmacists can use in an effort to enhance the screening capabilities for HCV infection. Pharmacists often have the most contact with those patients at high risk for having contracted HCV in the past. With a relatively high PPA and high NPA, a high confidence in the accuracy of the device can be placed on initial test results. Patients should then be triaged to proper follow-up care depending on initial results.
机译：目的：对社区药房中使用，阳性同意百分率（PPA），阴性同意百分率（PNA）以及在社区药房中使用OraQuick HCV快速抗体检测丙型肝炎病毒（HCV）的方法进行审查。在目标人群中进行总体HCV筛查。数据来源：在PubMed和Sagepub中搜索以下内容：丙型肝炎病毒，快速诊断检测，快速检测和快速HCV检测。搜索日期为2000年1月至2013年10月。研究选择：包括所有研究，包括使用OraQuick HCV快速抗体检测。数据综合：将该设备的敏感性和特异性与用于检测HCV抗体的几种标准实验室测试进行了比较。在将这些值与临床“标准”进行比较时，PPA和PNA是更适用的术语，用于描述OraQuick设备是否是药剂师进行初步筛查的有效工具。 OraQuick HCV快速抗体测试证明了提供准确HCV感染状态的准确性。结论：OraQuick HCV快速抗体检测是药剂师可用于增强HCV感染筛查能力的独特工具。药剂师通常与过去接触过HCV的高风险患者接触最多。在较高的PPA和较高的NPA的情况下，可以在初始测试结果上放心对设备的准确性。然后应根据初步结果对患者进行分类以进行适当的后续护理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号